GlobeImmune Inc (GBIM)
0.00
USD |
OTCM |
Apr 18, 16:00
GlobeImmune Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2016 | -91.46% |
| December 31, 2015 | -75.87% |
| September 30, 2015 | 30.34% |
| June 30, 2015 | -102.2% |
| March 31, 2015 | -131.4% |
| December 31, 2014 | -115.3% |
| September 30, 2014 | -486.9% |
| June 30, 2014 | -330.1% |
| March 31, 2014 | -172.4% |
| Date | Value |
|---|---|
| December 31, 2013 | 77.02% |
| September 30, 2013 | -30.28% |
| June 30, 2013 | 25.60% |
| March 31, 2013 | -72.77% |
| June 30, 2012 | -33.84% |
| March 31, 2012 | -85.03% |
| June 30, 2011 | -327.3% |
| March 31, 2011 | -313.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |